UPDATE : Monday, February 18, 2019
상단여백
Ministry OKs Peptron’s P2 clinical trial of Parkinson’s disease treatment
Peptron said Monday that the Ministry of Food and Drug Safety has approved ...
by Lee Han-soo  |  2019-02-18 11:13
라인
Sillajen’s research selected as cover paper for international journal
Sillajen said Friday that the Clinical Cancer Research, an international jo...
by Lee Han-soo  |  2019-02-15 17:36
라인
SK Biopharmaceuticals, Arvelle to develop, commercialize cenobamate in Europe
SK Biopharmaceuticals said Thursday that it has signed an exclusive licensi...
by Lee Han-soo  |  2019-02-15 15:36
라인
Acute myeloid leukemia treatment Rydapt approved as orphan drug
The regulatory agency approved Rydapt 25mg (ingredient: midostaurin), a tre...
by Lee Hye-seon  |  2019-02-15 15:36
라인
Sanofi Genzyme Korea launches rare blood disorder franchise
Sanofi Genzyme Korea, a subsidiary of Sanofi, said Thursday that it has lau...
by Lee Han-soo  |  2019-02-15 14:37
라인
GC starts P2 trials of hepatitis B treatment
GC said Thursday that it has administered the first dose of GC1102, a new r...
by Lee Han-soo  |  2019-02-15 14:36
라인
MSD leads rapidly growing antidiabetic DPP-4 inhibitors market
MSD took the No. 1 position in sales of antidiabetic dipeptidyl peptidase-4...
by Kim Yun-mi  |  2019-02-15 14:31
라인
Dong-A ST posts ₩567.2 billion in 2018 sales
Dong-A ST said Wednesday that it recorded the sales of 567.2 billion ($504....
by Lee Han-soo  |  2019-02-14 16:13
라인
Blood-thinning NOAC market expands 30% in 2018
The domestic market of non-vitamin K antagonist oral anticoagulants (NOAC) ...
by Kim Yun-mi  |  2019-02-14 12:12
라인
Yuhan’s subsidiary wins ₩43.5 billion funding
ImmuneOncia Therapeutics said Wednesday that it has completed a private equ...
by Lee Han-soo  |  2019-02-13 17:04
라인
Price cut, expanded indication to prop up cholesterol-reducing PCSK9 inhibitors
Physicians are likely to use cholesterol-lowering proprotein convertase sub...
by Kim Yun-mi  |  2019-02-13 16:11
라인
Mediforum gets ₩19 billion investment
Mediforum said Wednesday that it has received investment worth 19 billion w...
by Lee Han-soo  |  2019-02-13 15:19
라인
Genexine, SCM Life Science acquire Argos Therapeutics
Genexine and SCM Life Science said Wednesday that they took over Argos Ther...
by Lee Han-soo  |  2019-02-13 15:17
라인
CJ Healthcare to export gastroesophageal reflux treatment to Latin America
CJ Healthcare said Wednesday that it has signed a licensing agreement for K...
by Lee Han-soo  |  2019-02-13 10:50
라인
GC posts ₩1.3 trillion in 2018 sales
GC said Wednesday that it has recorded 1.3 trillion won ($1.1 billion) in s...
by Lee Han-soo  |  2019-02-13 10:50
라인
Bridge Biotherapeutics unveils clinical trials results for ulcerative colitis treatment
Bridge Biotherapeutics said it presented the preclinical and phase 1 study ...
by Lee Han-soo  |  2019-02-12 17:38
라인
AbbVie’s new hepatitis C treatment outpaces Gilead’s rival drugs
AbbVies’s new hepatitis C therapy Mavyret (glecaprevir/pibrentasvir), a fol...
by Kim Yun-mi  |  2019-02-12 15:56
라인
Pfizer Korea voluntarily recalls antibiotic Zyvox
Pfizer Korea said it voluntarily recalled some of Zyvox 600mg (ingredient: ...
by Lee Hye-seon  |  2019-02-12 15:56
라인
SK Chemical to co-promote Janssen’s dementia treatment
SK Chemical said Tuesday that it has signed an agreement with Janssen Korea...
by Lee Han-soo  |  2019-02-12 15:55
라인
Demands for MMR vaccines spike amid resurgence of measles
Amid a rise of measles patients, clinics are suffering a shortage of MMR (m...
by Park Gi-taek  |  2019-02-12 11:19
여백
여백
여백
Back to Top